BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells

Cellular Oncology

Volumn 37, Issue 5, 2014, Pages 363-375

  Wan, Shaoheng ^a   Liu, Yuehong ^a   Weng, Yaguang ^a   Wang, Wei ^a   Ren, Wei ^a   Fei, Chang ^a   Chen, Yingying ^a   Zhang, Zhihui ^a   Wang, Ting ^a   Wang, Jinshu ^a   Jiang, Yayun ^a   Zhou, Lan ^a   He, Tongchuan ^b   Zhang, Yan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

BMP9; Bone marrow derived mesenchymal stem cells; Breast cancer; Cross talk; RANKL RANK axis

Indexed keywords

ALIZARIN RED S; BONE MORPHOGENETIC PROTEIN 9; GELATINASE A; GELATINASE B; INTERLEUKIN 11; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; CULTURE MEDIUM; GDF2 PROTEIN, HUMAN; GROWTH DIFFERENTIATION FACTOR; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BREAST CANCER; CANCER GROWTH; CELL CULTURE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY ASSAY; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HCT116 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; MOLECULAR INTERACTION; NONHUMAN; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TOTAL HIP PROSTHESIS; WESTERN BLOTTING; WOUND HEALING; ANIMAL; BONE DEVELOPMENT; BREAST TUMOR; CELL COMMUNICATION; CELL LINE; CELL MOTION; COCULTURE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STROMA CELL; METABOLISM; NUDE MOUSE; PATHOLOGY; PHARMACOLOGY; PROCEDURES; TUMOR CELL LINE;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL COMMUNICATION; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH DIFFERENTIATION FACTORS; HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STROMAL CELLS; MICE, NUDE; OSTEOGENESIS; PROTO-ONCOGENE PROTEINS C-AKT; RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84907734870     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-014-0197-1     Document Type: Article

References (40)

1. A. Halon, P. Donizy, P. Surowiak, R. Matkowski, ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up. Cell Oncol (Dordr) 36, 181-190 (2013)
2. A. Lipton, R. Uzzo, R.J. Amato, G.K. Ellis, B. Hakimian, G.D. Roodman, M.R. Smith, The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors. J Natl Compr Cancer Netw 7(Suppl 7), S1-S29 (2009). quiz S30
3. I. Zinonos, K.W. Luo, A. Labrinidis, V. Liapis, S. Hay, V. Panagopoulos, M. Denichilo, C.H. Ko, G.G. Yue, C.B. Lau, W. Ingman, V. Ponomarev, G.J. Atkins, D.M. Findlay, A.C. Zannettino, A. Evdokiou, Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. Int. J. Oncol. 45, 532-540 (2014)
4. R.L. Theriault, R.L. Theriault, Biology of bone metastases. Cancer Control 19, 92-101 (2012)
5. R. Krawetz, Y.E. Wu, D.E. Rancourt, J. Matyas, Osteoblasts suppress high bone turnover caused by osteolytic breast cancer in-vitro. Exp. Cell Res. 315, 2333-2342 (2009)
6. P.O. Favaron, A. Mess, S.E. Will, P.C. Maiorka, M.F. de Oliveira, M.A. Miglino, Yolk sac mesenchymal progenitor cells from New World mice (Necromys lasiurus) with multipotent differential potential. PLoS One 9, e95575 (2014)
7. J. Luo, M. Tang, J. Huang, B.C. He, J.L. Gao, L. Chen, G.W. Zuo, W. Zhang, Q. Luo, Q. Shi, B.Q. Zhang, Y. Bi, X. Luo, W. Jiang, Y. Su, J. Shen, S.H. Kim, E. Huang, Y. Gao, J.Z. Zhou, K. Yang, H.H. Luu, X. Pan, R.C. Haydon, Z.L. Deng, T.C. He, TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J. Biol. Chem. 285, 29588-29598 (2010)
8. D. Mendoza-Villanueva, L. Zeef, P. Shore, Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin. Breast Cancer Res. 13, R106 (2011)
9. A.P. Molloy, F.T. Martin, R.M. Dwyer, T.P. Griffin, M. Murphy, F.P. Barry, T. O'Brien, M.J. Kerin, Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int. J. Cancer 124, 326-332 (2009)
10. K. Wang, H. Feng, W. Ren, X. Sun, J. Luo, M. Tang, L. Zhou, Y. Weng, T.C. He, Y. Zhang, BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231. J. Cancer Res. Clin. Oncol. 137, 1687-1696 (2011)
11. X. Sun, K. Wang, H. Feng, Effects and possible mechanism of BMP9 on the bone metastasis of human breast cancer cells MDA-MB- 231. Chin Biotechnol 32, 7-13 (2012)
12. N. Tang, W.X. Song, J. Luo, X. Luo, J. Chen, K.A. Sharff, Y. Bi, B.C. He, J.Y. Huang, G.H. Zhu, Y.X. Su, W. Jiang, M. Tang, Y. He, Y. Wang, L. Chen, G.W. Zuo, J. Shen, X. Pan, R.R. Reid, H.H. Luu, R.C. Haydon, T.C. He, BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J. Cell. Mol. Med. 13, 2448-2464 (2009)
13. N. Serna-Marquez, S. Villegas-Comonfort, O. Galindo-Hernandez, N. Navarro-Tito, A. Millan, E.P. Salazar, Role of LOXs and COX-2 on FAK activation and cell migration induced by linoleic acid in MDA-MB-231 breast cancer cells. Cell Oncol 36, 65-77 (2013)
14. J.S. Park, S.Y. Choi, J.H. Lee, J.H. Lee, M. Lee, E.S. Nam, A.L. Jeong, S. Lee, S. Han, M.S. Lee, J.S. Lim, Y. Yoon do, Y. Kwon, Y. Yang, Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway. Cell Oncol 36, 493-503 (2013)
15. H.H. Luu, W.X. Song, X. Luo, D. Manning, J. Luo, Z.L. Deng, K.A. Sharff, A.G. Montag, R.C. Haydon, T.C. He, Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J. Orthop. Res. 25, 665-677 (2007)
16. J.A. Sterling, S.A. Guelcher, Bone structural components regulating sites of tumor metastasis. Curr Osteoporos Rep 9, 89-95 (2011)
17. J.L. Gilmore, J.A. Scott, Z. Bouizar, A. Robling, S.E. Pitfield, D.J. Riese 2nd, J. Foley, Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells. Breast Cancer Res. Treat. 110, 493-505 (2008)
18. S. Ley, A. Weigert, B. Weichand, N. Henke, B. Mille-Baker, R.A. Janssen, B. Brune, The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages. Oncogene 32, 631-640 (2013)
19. J.Y. Jang, Y.K. Jeon, C.W. Kim, Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells. BMC Cancer 10, 391 (2010)
20. K. Tawara, J.T. Oxford, C.L. Jorcyk, Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies. Cancer Manag. Res. 3, 177-189 (2011)
21. Y. Guo, P.F. Li, X.C. Shu, H. Deng, H.L. Ma, L. Sun, Involvement of Wnt/beta-catenin signaling in the osteogenesis of bone marrow mesenchymal stem cells induced by drynaria total flavonoids. Zhonghua Yi Xue Za Zhi 92, 2288-2291 (2012)
22. L. Zhang, Y. Teng, Y. Zhang, J. Liu, L. Xu, J. Qu, K. Hou, X. Yang, Y. Liu, X. Qu, C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway. Oncol Lett 3, 395-400 (2012)
23. Y. Zhang, L. Wang, M. Zhang, M. Jin, C. Bai, X. Wang, Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of EGF-EGFR-PI3K-Akt-Erk pathway. J. Cell. Physiol. 227, 35-43 (2012)
24. S. Ibaragi, T. Shimo, M. Iwamoto, N.M. Hassan, S. Kodama, S. Isowa, A. Sasaki, Parathyroid hormone-related peptide regulates matrix metalloproteinase-13 gene expression in bone metastatic breast cancer cells. Anticancer Res. 30, 5029-5036 (2010)
25. L. Zhang, Y. Teng, Y. Zhang, J. Liu, L. Xu, J. Qu, K. Hou, Y. Liu, X. Qu, Proteasome inhibitor bortezomib (PS-341) enhances RANKL-induced MDA-MB-231 breast cancer cell migration. Mol Med Rep 5, 580-584 (2012)
26. L. Ye, H. Kynaston, W.G. Jiang, Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4. Mol. Cancer Res. 6, 1594-1606 (2008)
27. L. Ye, H. Kynaston, W.G. Jiang, Bone morphogenetic protein-10 suppresses the growth and aggressiveness of prostate cancer cells through a Smad independent pathway. J. Urol. 181, 2749-2759 (2009)
28. W. Irvin Jr., H.B. Muss, D.K. Mayer, Symptom management in metastatic breast cancer. Oncologist 16, 1203-1214 (2011)
29. Y.C. Chen, D.M. Sosnoski, A.M. Mastro, Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res. 12, 215 (2010)
30. W. Ren, X. Sun, K. Wang, H. Feng, Y. Liu, C. Fei, S. Wan, W. Wang, J. Luo, Q. Shi, M. Tang, G. Zuo, Y. Weng, T. He, Y. Zhang, BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression. Mol. Biol. Rep. 41, 1373-1383 (2014)
31. Y.H. Wang, Y.Y. Dong, W.M. Wang, X.Y. Xie, Z.M. Wang, R.X. Chen, J. Chen, D.M. Gao, J.F. Cui, Z.G. Ren, Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines. J. Exp. Clin. Cancer Res. 32, 51 (2013)
32. A. De Luca, L. Lamura, M. Gallo, V. Maffia, N. Normanno, Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. J. Cell. Biochem. 113, 3363-3370 (2012)
33. L.E. Wright, J.B. Frye, A.L. Lukefahr, B.N. Timmermann, K.S. Mohammad, T.A. Guise, J.L. Funk, Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis. J. Nat. Prod. 76, 316-321 (2013)
34. S. Das, R.S. Samant, L.A. Shevde, Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis. J. Biol. Chem. 286, 9612-9622 (2011)
35. S. Das, J.A. Tucker, S. Khullar, R.S. Samant, L.A. Shevde, Hedgehog signaling in tumor cells facilitates osteoblast-enhanced osteolytic metastases. PLoS One 7, e34374 (2012)
36. T.A. Owen, M. Aronow, V. Shalhoub, L.M. Barone, L. Wilming, M.S. Tassinari, M.B. Kennedy, S. Pockwinse, J.B. Lian, G.S. Stein, Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 143, 420-430 (1990)
37. G. Bu, W. Lu, C.C. Liu, K. Selander, T. Yoneda, C. Hall, E.T. Keller, Y. Li, Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases. Int. J. Cancer 123, 1034-1042 (2008)
38. Z. Zhai, X. Qu, W. Yan, H. Li, G. Liu, X. Liu, T. Tang, A. Qin, K. Dai, Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling. Breast Cancer Res. Treat. 144, 33-45 (2014)
39. N. Kurio, T. Shimo, T. Fukazawa, M. Takaoka, T. Okui, N.M. Hassan, T. Honami, S. Hatakeyama, M. Ikeda, Y. Naomoto, A. Sasaki, Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo. Exp. Cell Res. 317, 1134-1146 (2011)
40. C. Bolin, K. Tawara, C. Sutherland, J. Redshaw, P. Aranda, J. Moselhy, R. Anderson, C.L. Jorcyk, Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation. Genes Cancer 3, 117-130 (2012)